Please provide your email address to receive an email when new articles are posted on . Patients treated with dupilumab experienced statistically significant improvements in transepidermal water loss.
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--jCyte, Inc., today announced key findings presented at AAO 2021 which demonstrated that retinitis pigmentosa (RP) patients with a baseline central visual field ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results